Critically discuss the existing evidence from clinical trials on the effect of dietary polyphenols on CVD risk (2500)
• CVD prevalence and population( NO/PERCENTAGE) in danger, why is important to focus on CVD population?—possible development for other metabolic syndrome?
• Given the background information about the benefits of polyphenol on metabolic syndrome, Trying to build linkage between polyphenol intake and CVD risk from epidemiological research/observational research and animal model.
• Talking about disadvantages of previous studies and why clinical trial is important?
• Then Given that present study aims to focus on clinical trials only which try to give an overview on effects of polyphenols on CVD risk.
• State both sides’s view: Controversial evidence? on this field which give us reason to questioning whether polyphenol is beneficial for patient with CVD issues.
Papers are separated into two categories which are positive and negative result for the impact of polyphenol treatment on assessing the CVD risk.
Main body paragraph 01(600)
• Intake of polyphenol can decrease CVD risk
• my points of view and critics about mentioned papers
Main body paragraph 02 (600)
• Intake of polyphenol have no benefits for patients with CVD risk
• My points of view and critics about mentioned papers